Compare · SBRA vs VTR
SBRA vs VTR
Side-by-side comparison of Sabra Health Care REIT Inc. (SBRA) and Ventas Inc. (VTR): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both SBRA and VTR operate in Real Estate Investment Trusts (Real Estate), so they compete in similar markets.
- VTR is the larger of the two at $39.67B, about 8.7x SBRA ($4.57B).
- Over the past year, SBRA is down 2.6% and VTR is up 28.4% - VTR leads by 31.0 points.
- SBRA has been more active in the news (18 items in the past 4 weeks vs 5 for VTR).
- Both have 25 recent analyst ratings on file.
- Company
- Sabra Health Care REIT Inc.
- Ventas Inc.
- Price
- $18.12+0.33%
- $81.59-0.69%
- Market cap
- $4.57B
- $39.67B
- 1M return
- -13.76%
- -7.68%
- 1Y return
- -2.58%
- +28.38%
- Industry
- Real Estate Investment Trusts
- Real Estate Investment Trusts
- Exchange
- NASDAQ
- NYSE
- IPO
- News (4w)
- 18
- 5
- Recent ratings
- 25
- 25
Sabra Health Care REIT Inc.
As of September 30, 2020, Sabra's investment portfolio included 425 real estate properties held for investment (consisting of (i) 287 Skilled Nursing/Transitional Care facilities, (ii) 64 Senior Housing communities (ÂSenior Housing - LeasedÂ), (iii) 47 Senior Housing communities operated by third-party property managers pursuant to property management agreements (ÂSenior Housing - ManagedÂ) and (iv) 27 Specialty Hospitals and Other facilities), one asset held for sale, one investment in a direct financing lease, 19 investments in loans receivable (consisting of (i) one mortgage loan, (ii) one construction loan and (iii) 17 other loans), six preferred equity investments and one investment in an unconsolidated joint venture that owns 158 Senior Housing - Managed communities. As of September 30, 2020, Sabra's real estate properties held for investment included 42,378 beds/units and its unconsolidated joint venture included 7,056 beds/units, spread across the United States and Canada.
Ventas Inc.
Ventas, an S&P 500 company, operates at the intersection of two powerful and dynamic industries  healthcare and real estate. As one of the world's foremost Real Estate Investment Trusts (REIT), we use the power of capital to unlock the value of real estate, partnering with leading care providers, developers, research and medical institutions, innovators and healthcare organizations whose success is buoyed by the demographic tailwind of an aging population. For more than twenty years, Ventas has followed a successful strategy that endures: combining a high-quality diversified portfolio of properties and capital sources to manage through cycles, working with industry leading partners, and a collaborative and experienced team focused on producing consistent growing cash flows and superior returns on a strong balance sheet, ultimately rewarding Ventas shareholders. As of September 30, 2020, Ventas owned or managed through unconsolidated joint ventures approximately 1,200 properties.
Latest SBRA
- Director Malehorn Jeffrey A. was granted 8,310 shares, increasing direct ownership by 8% to 116,346 units (SEC Form 4)
- Director Kono Ann was granted 8,310 shares, increasing direct ownership by 14% to 68,186 units (SEC Form 4)
- Director Katzmann Lynne S was granted 8,310 shares, increasing direct ownership by 11% to 86,121 units (SEC Form 4)
- Director Foster Michael J was granted 8,310 shares, increasing direct ownership by 11% to 82,043 units (SEC Form 4)
- Director Cusack Catherine was granted 8,310 shares, increasing direct ownership by 11% to 82,056 units (SEC Form 4)
- Director Barbarosh Craig A. was granted 8,310 shares, increasing direct ownership by 15% to 63,326 units (SEC Form 4)
- Sabra Health Care REIT Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders
- Raymond James resumed coverage on Sabra Health Care REIT
- Executive VP, CIO & Secretary Smith Darrin was granted 501 shares, increasing direct ownership by 0.43% to 116,424 units (SEC Form 4)
- Executive VP, CFO & Treasurer Costa Michael Lourenco was granted 4,200 shares, increasing direct ownership by 0.91% to 465,721 units (SEC Form 4)
Latest VTR
- Raymond James resumed coverage on Ventas with a new price target
- Ventas Inc. filed SEC Form 8-K: Leadership Update, Other Events
- Director Embler Michael J bought $197,025 worth of shares (2,500 units at $78.81), increasing direct ownership by 15% to 19,202 units (SEC Form 4)
- Ventas Chairman and CEO Debra A. Cafaro to Receive Cyrus McCormick Making History Award for Historic Corporate Achievement
- Ventas Issues Business Update and Will Participate in Investor Meetings at Nareit's REITweek 2026 Investor Conference
- Ventas Inc. filed SEC Form 8-K: Leadership Update, Submission of Matters to a Vote of Security Holders, Other Events
- Director Roy Sumit was granted 2,047 shares, increasing direct ownership by 9% to 24,404 units (SEC Form 4)
- Director Smith Maurice S was granted 2,047 shares, increasing direct ownership by 7% to 30,723 units (SEC Form 4)
- Director Rakowich Walter C was granted 2,047 shares and sold $103,915 worth of shares (1,152 units at $90.20) as part of a pre-agreed trading plan, increasing direct ownership by 3% to 28,349 units (SEC Form 4)
- Director Rodriguez Joe Vasquez Jr. was granted 2,047 shares, increasing direct ownership by 26% to 9,895 units (SEC Form 4)